Patents by Inventor Hiroyasu Esumi

Hiroyasu Esumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210170026
    Abstract: Provided are an anticancer agent, radiosensitizer, and food composition capable of enhancing the effects of radiation therapy. The present inventors discovered that tumors shrink significantly in comparison to an untreated group and the respective monotherapy groups when treatment by burdock fruit extract containing arctigenin and radiation therapy were used in combination on mice transplanted with human pancreatic cancer cells. The anticancer agent of the present invention is an anticancer agent containing arctigenin and/or arctiin as the active ingredient, to be used in combination with radiation therapy. The arctigenin and/or arctiin may be contained as burdock, burdock fruit, burdock sprout, or forsythia, or an extract extracted from these.
    Type: Application
    Filed: July 10, 2017
    Publication date: June 10, 2021
    Applicants: KRACIE PHARMA, LTD., NATIONAL CANCER CENTER, TOKYO UNIVERSITY OF SCIENCE FOUNDATION
    Inventors: Hiroyasu ESUMI, Katsuya TSUCHIHARA, Takanori KAWASHIMA
  • Patent number: 9907852
    Abstract: The purpose of the present invention is to provide an anticancer agent for potentiating an antitumor effect, alleviating side effects, and further extending the survival rate by concomitant use with a component having an anticancer effect. An anticancer agent combining arctigenin and a component other than arctigenin that has an anticancer effect, in which the anticancer agent may be a combination drug or may be a kit configured from a formulation containing arctigenin and a formulation containing a component that has an anticancer effect, and the concomitant use of arctigenin and the component having an anticancer effect more strongly inhibits tumor growth and reduces the proportion of cancer stem cells in the tumor, making it possible to extend the total survival time and to alleviate side effects caused by the component having an anticancer effect.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: March 6, 2018
    Assignees: National University Corporation University of Toyama, Kracie Pharma, Ltd., National Cancer Center, Tokyo University of Science Foundation
    Inventors: Hiroyasu Esumi, Masafumi Ikeda, Katsuya Tsuchihara, Shigeki Chiba, Satoshi Yomoda, Takanori Kawashima, Toshiki Okubo, Yasuhiro Tezuka, Kenta Murata
  • Patent number: 9700572
    Abstract: The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient so that a dose of arctigenin was 100 mg or more per day, the tumor reducing effect was observed, and, in addition, lowering of tumor markers was confirmed. The present invention provides an anticancer agent containing arctigenin, wherein a dose of the arctigenin is 100 mg or more per day. In addition, the present invention provides the anticancer agent containing arctigenin and arctiin at a weight ratio of arctigenin/arctiin=0.7 to 1.3.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: July 11, 2017
    Assignees: National Cancer Center, Kracie Pharma, Ltd., National University Corporation University of Toyama
    Inventors: Hiroyasu Esumi, Masafumi Ikeda, Chika Miyoshi, Shigetoshi Kadota, Toshiki Okubo, Satoshi Yomoda, Takafumi Fuse, Takanori Kawashima, Shigeki Chiba
  • Patent number: 9586921
    Abstract: PROBLEM TO BE SOLVED A burdock fruit extract containing arctigenin at high content and its production method are provided, and both of which are used for treatment of pancreatic cancer. SOLUTION The burdock fruit extract containing arctigenin at high content by enzymatically converted arctiin into arctigenin with beta-glucosidase, which is an enzyme occurring endogenously in a burdock fruit, and adding ethanol, extracting, concentrating and then freeze-drying or spray drying.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: March 7, 2017
    Assignees: Kracie Pharma, Ltd., Japan as Represented by President of National Cancer Center, National University Corporation University of Toyama
    Inventors: Keiichi Yamamoto, Toshiki Okubo, Satoshi Yomoda, Hiroyasu Esumi, Chika Miyoshi, Shigetoshi Kadota
  • Publication number: 20170028065
    Abstract: The purpose of the present invention is to provide an anticancer agent for potentiating an antitumor effect, alleviating side effects, and further extending the survival rate by concomitant use with a component having an anticancer effect. An anticancer agent combining arctigenin and a component other than arctigenin that has an anticancer effect, in which the anticancer agent may be a combination drug or may be a kit configured from a formulation containing arctigenin and a formulation containing a component that has an anticancer effect, and the concomitant use of arctigenin and the component having an anticancer effect more strongly inhibits tumor growth and reduces the proportion of cancer stem cells in the tumor, making it possible to extend the total survival time and to alleviate side effects caused by the component having an anticancer effect.
    Type: Application
    Filed: April 10, 2015
    Publication date: February 2, 2017
    Applicants: National University Corporation University of Toyama, Kracie Pharma, Ltd., National Cancer Center, Tokyo University of Science Foundation
    Inventors: Hiroyasu Esumi, Kouji IKEDA, Katsuya TSUCHIHARA, Shigeki Chiba, Satoshi Yomoda, Takanori Kawashima, Toshiki Okubo, Yasuhiro TEZUKA, Kenta MURATA
  • Publication number: 20150196576
    Abstract: The present invention is intended to provide a novel anticancer agent which is effective to a cancer. After administering an agent prepared using burdock fruit extract to a pancreas cancer patient so that a dose of arctigenin was 100 mg or more per day, the tumor reducing effect was observed, and, in addition, lowering of tumor markers was confirmed. The present invention provides an anticancer agent containing arctigenin, wherein a dose of the arctigenin is 100 mg or more per day. In addition, the present invention provides the anticancer agent containing arctigenin and arctiin at a weight ratio of arctigenin/arctiin=0.7 to 1.3.
    Type: Application
    Filed: September 24, 2014
    Publication date: July 16, 2015
    Inventors: Hiroyasu ESUMI, Masafumi IKEDA, Chika MIYOSHI, Shigetoshi KADOTA, Toshiki OKUBO, Satoshi YOMODA, Takafumi FUSE, Takanori KAWASHIMA, Shigeki CHIBA
  • Patent number: 9072718
    Abstract: PROBLEM TO BE SOLVED The present invention is intended to provide a burdock fruit extract comprising arctigenin and arctiin at a definite ratio and a method for producing the same. More particularly, the present invention is intended to provide a method for producing a burdock fruit extract comprising arctigenin and arctiin at a weight ratio of approximately 1:1. SOLUTION A method for producing a burdock fruit extract comprising arctigenin and arctiin at a weight ratio of arctigenin/arctiin=0.7 to 1.3 is provided, including the steps of: cutting a burdock fruit and converting arctiin which is inherent in the burdock fruit into arctigenin by enzymatic conversion by beta-glucosidase which is inherent in the burdock fruit, wherein the enzymatic conversion includes reaction at a temperature from 20° C. to 50° C. Also provided is the method further including a step of extracting an extract comprising arctigenin and arctiin by adding an organic solvent and heating to reflux.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: July 7, 2015
    Assignees: National University Corporation University of Toyama, Kracie Pharma, Ltd., National Cancer Center
    Inventors: Toshiki Okubo, Satoshi Yomoda, Takafumi Fuse, Takanori Kawashima, Hiroyasu Esumi, Chika Miyoshi, Shigetoshi Kadota
  • Publication number: 20120029070
    Abstract: PROBLEM TO BE SOLVED A burdock fruit extract containing arctigenin at high content and its production method are provided, and both of which are used for treatment of pancreatic cancer. SOLUTION The burdock fruit extract containing arctigenin at high content by enzymatically converted arctiin into arctigenin with beta-glucosidase, which is an enzyme occurring endogenously in a burdock fruit, and adding ethanol, extracting, concentrating and then freeze-drying or spray drying.
    Type: Application
    Filed: February 5, 2010
    Publication date: February 2, 2012
    Applicant: Kracie Pharma, Ltd.
    Inventors: Keiichi Yamamoto, Toshiki Okubo, Satoshi Yomoda, Hiroyasu Esumi, Chika Miyoshi, Shigetoshi Kadota